Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells

[1]  K. Itoh,et al.  Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells , 2014, Neuroscience Research.

[2]  S. Ovsepian,et al.  Drain of the brain: low-affinity p75 neurotrophin receptor affords a molecular sink for clearance of cortical amyloid β by the cholinergic modulator system , 2013, Neurobiology of Aging.

[3]  Lan Ma,et al.  Modeling heterogeneous responsiveness of intrinsic apoptosis pathway , 2013, BMC Systems Biology.

[4]  H. Rupasinghe,et al.  Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases , 2013, Oxidative medicine and cellular longevity.

[5]  Bhaswati Banerjee,et al.  Caspases: A Potential Therapeutic Targets in the Treatment of Alzheimer's Disease , 2013 .

[6]  B. Winblad,et al.  The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease , 2013, PloS one.

[7]  K. Itoh,et al.  Carnosic acid suppresses the production of amyloid-β 1–42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells , 2013, Neuroscience Research.

[8]  O. Arancio,et al.  Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection , 2012, Molecular Neurodegeneration.

[9]  W. Klein.  Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? , 2012, Journal of Alzheimer's disease : JAD.

[10]  F. Cecconi,et al.  Caspase-3 in the central nervous system: beyond apoptosis , 2012, Trends in Neurosciences.

[11]  A. Kakita,et al.  p62/sequestosome 1 binds to TDP‐43 in brains with frontotemporal lobar degeneration with TDP‐43 inclusions , 2012, Journal of neuroscience research.

[12]  Rajesh S. Omtri,et al.  Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery. , 2012, Molecular pharmaceutics.

[13]  Morgan Sheng,et al.  Caspases in synaptic plasticity , 2012, Molecular Brain.

[14]  V. de Laurenzi,et al.  Role of Apoptosis in disease , 2012, Aging.

[15]  W. Klein,et al.  Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity , 2012, Neurobiology of Aging.

[16]  W. Klein,et al.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease , 2011, Neurobiology of Learning and Memory.

[17]  M. Modo,et al.  Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke , 2011, The Journal of physiology.

[18]  C. Broeckhoven,et al.  Potent amyloidogenicity and pathogenicity of Aβ43 , 2011, Nature Neuroscience.

[19]  K. Itoh,et al.  Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes. , 2011, Journal of biochemistry.

[20]  T. Dawson,et al.  Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos) , 2011, Science Signaling.

[21]  K. Itoh,et al.  Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation , 2011, Neuroscience Research.

[22]  J. McLaurin,et al.  Mechanisms of Amyloid-Beta Peptide Uptake by Neurons: The Role of Lipid Rafts and Lipid Raft-Associated Proteins , 2010, International journal of Alzheimer's disease.

[23]  D. Linseman,et al.  Nutraceutical Antioxidants as Novel Neuroprotective Agents , 2010, Molecules.

[24]  Gopal Thinakaran,et al.  Membrane rafts in Alzheimer's disease beta-amyloid production. , 2010, Biochimica et biophysica acta.

[25]  C. Schengrund.  Lipid rafts: Keys to neurodegeneration , 2010, Brain Research Bulletin.

[26]  W. Klein,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[27]  T. Rohn.  The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities , 2010, Apoptosis.

[28]  B. Winblad,et al.  Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains , 2009, Journal of neurochemistry.

[29]  H. Tanila,et al.  Nuclear factor erythroid 2-related factor 2 protects against beta amyloid , 2008, Molecular and Cellular Neuroscience.

[30]  F. Baas,et al.  Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake. , 2008, Biochimica et biophysica acta.

[31]  H. Chun,et al.  Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death , 2008, Neuroreport.

[32]  R. Resende,et al.  Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death , 2008, Neuroscience.

[33]  T. Terasaki,et al.  Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexes , 2007, Journal of neurochemistry.

[34]  T. Iwatsubo,et al.  Immunoreactivity of phage library-derived human single-chain antibodies to amyloid beta conformers in vitro. , 2007, Journal of biochemistry.

[35]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[36]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[37]  D. Dickson,et al.  Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease , 2006 .

[38]  A. Yoshimura,et al.  ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1 , 2006, Journal of Cell Science.

[39]  G. Bu,et al.  Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier , 2004, Journal of Cell Science.

[40]  D. Dickson.  Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? , 2004, The Journal of clinical investigation.

[41]  T. Kudo,et al.  Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death , 2004, The Journal of cell biology.

[42]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  David S. Park,et al.  Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death , 2002, The Journal of cell biology.

[44]  F. Checler,et al.  The caspase‐derived C‐terminal fragment of βAPP induces caspase‐independent toxicity and triggers selective increase of Aβ42 in mammalian cells , 2001, Journal of neurochemistry.

[45]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[46]  Mark P. Mattson,et al.  Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.

[47]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[48]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[49]  C. Cotman,et al.  Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8 , 1999, Neurobiology of Disease.

[50]  P. Rakic,et al.  The role of cell death in regulating the size and shape of the mammalian forebrain. , 1999, Cerebral cortex.

[51]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[52]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[53]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[54]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[55]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[56]  B. Margolis,et al.  The X11α Protein Slows Cellular Amyloid Precursor Protein Processing and Reduces Aβ40 and Aβ42 Secretion* , 1998, The Journal of Biological Chemistry.

[57]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[58]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[59]  Masahiko S. Satoh,et al.  Role of poly(ADP-ribose) formation in DNA repair , 1992, Nature.

[60]  K. Itoh,et al.  Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. , 2010, Journal of biochemistry.

[61]  M. Kirkitadze,et al.  Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease. , 2005, Acta biochimica Polonica.

[62]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.